ClinVar Miner

Submissions for variant NM_000251.2(MSH2):c.317G>A (p.Arg106Lys) (rs41295286)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000115525 SCV000172850 benign Hereditary cancer-predisposing syndrome 2015-03-10 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Co-occurence with a mutation in another gene that clearly explains a proband's phenotype,Does not segregate with disease in family study (genes with incomplete penetrance),In silico models in agreement (benign),Other data supporting benign classification
Color RCV000115525 SCV000910795 benign Hereditary cancer-predisposing syndrome 2016-10-03 criteria provided, single submitter clinical testing
DNA and Cytogenetics Diagnostics Unit,Erasmus Medical Center RCV000172812 SCV000744265 benign Lynch syndrome I 2015-09-21 criteria provided, single submitter clinical testing
GeneDx RCV000202010 SCV000149434 likely benign not specified 2017-10-27 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Integrated Genetics/Laboratory Corporation of America RCV000588805 SCV000696260 likely benign not provided 2016-08-01 criteria provided, single submitter clinical testing Variant summary: The MSH2 c.317G>A (p.Arg106Lys) variant involves the alteration of a non-conserved nucleotide. 4/4 in silico tools predict a benign outcome for this variant (SNPs&GO not captured due to low reliability index). This variant was found in 9/123686 control chromosomes at a frequency of 0.0000728, which does not exceed the estimated maximal expected allele frequency of a pathogenic MSH2 variant (0.0005683). This variant has been reported in a proband from LS family with lack of co-segregation of this variant with disease. This patient also carried a pathogenic variant in MLH1, which could explain the patients phenotype. The variant of interest has also been reported in a case-control study with comparable allele frequency detected in the control and case cohorts. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign/likely benign and two clinical labs classified this variant as VUS, all without evidence to independently evaluate. Taken together, the variant was classified as likely benign until additional information becomes available.
International Society for Gastrointestinal Hereditary Tumours (InSiGHT) RCV000076564 SCV000107594 no known pathogenicity Lynch syndrome 2013-09-05 reviewed by expert panel research Multifactorial likelihood analysis posterior probability <0.001
Invitae RCV000524402 SCV000284165 likely benign Hereditary nonpolyposis colon cancer 2018-01-12 criteria provided, single submitter clinical testing
Mayo Clinic Genetic Testing Laboratories,Mayo Clinic RCV000202010 SCV000257184 uncertain significance not specified no assertion criteria provided research
Pathway Genomics RCV000172812 SCV000223778 benign Lynch syndrome I 2014-10-30 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.